We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner

News   Mar 28, 2012

 
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
 
 
Advertisement
 

RELATED ARTICLES

Epigenetic Mechanisms of Blood Cell Differentiation

News

Researchers have shown that the correct dosage of the enzyme MOF, an epigenetic regulator, can have a significant influence on blood stem cell fate.

READ MORE

How Do Plants Forget?

News

An international group of researchers found the answer to the question: how do plants forget?

READ MORE

First Epigenetic Study in 3D Human Cancer Cells Performed

News

The first massive epigenetic characterization in 3D cancer cultures or "organoids" has been performed. The resulting data is available to the research community to facilitate new findings on tumor development and progression.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE